A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors (clinicaltrials.gov) - Oct 1, 2026 - P=N/A | N=100 | Active, not recruiting | Sponsor: Ohio State University Comprehensive Cancer Center | Trial completion date: Jul 2026 ➔ Jul 2027 | Trial primary completion date: Jul 2026 ➔ Jul 2027
Biomarker • Checkpoint inhibition • IO biomarker • Trial completion date • Trial primary completion date • Genito-urinary Cancer • Lung Cancer • Lung Non-Small Cell Squamous Cancer • Non Small Cell Lung Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
|